Haverford Trust Company’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $13.8M | Sell |
62,575
-2,655
| -4% | -$734K | 0.12% | 97 |
|
|
2026
Q1 | $19.3M | Sell |
65,230
-707
| -1% | -$210K | 0.18% | 83 |
|
|
2025
Q4 | $18M | Sell |
65,937
-892
| -1% | -$242K | 0.16% | 86 |
|
|
2025
Q3 | $18.1M | Sell |
66,829
-840
| -1% | -$229K | 0.16% | 83 |
|
|
2025
Q2 | $18.7M | Sell |
67,669
-1,461
| -2% | -$397K | 0.18% | 84 |
|
|
2025
Q1 | $18.3M | Sell |
69,130
-944
| -1% | -$233K | 0.18% | 81 |
|
|
2024
Q4 | $16.3M | Sell |
70,074
-1,533
| -2% | -$353K | 0.16% | 84 |
|
|
2024
Q3 | $15.8M | Sell |
71,607
-555
| -0.8% | -$115K | 0.15% | 84 |
|
|
2024
Q2 | $14.2M | Buy |
72,162
+869
| +1% | +$180K | 0.15% | 87 |
|
|
2024
Q1 | $15.3M | Buy |
71,293
+1,281
| +2% | +$269K | 0.16% | 84 |
|
|
2023
Q4 | $14.7M | Buy |
70,012
+1,550
| +2% | +$331K | 0.16% | 82 |
|
|
2023
Q3 | $13.7M | Sell |
68,462
-395
| -0.6% | -$78.5K | 0.17% | 81 |
|
|
2023
Q2 | $12.8M | Buy |
68,857
+4,972
| +8% | +$919K | 0.14% | 81 |
|
|
2023
Q1 | $12.2M | Buy |
+63,885
| New | +$11.6M | 0.15% | 82 |
|
|
2022
Q2 | – | Sell |
-944
| Closed | -$225K | – | 338 |
|
|
2022
Q1 | $225K | Sell |
944
-106
| -10% | -$24.9K | ﹤0.01% | 341 |
|
|
2021
Q4 | $240K | Buy |
1,050
+6
| +0.6% | +$1.32K | ﹤0.01% | 333 |
|
|
2021
Q3 | $202K | Sell |
1,044
-23
| -2% | -$4.66K | ﹤0.01% | 353 |
|
|
2021
Q2 | $227K | Sell |
1,067
-77
| -7% | -$16.3K | ﹤0.01% | 329 |
|
|
2021
Q1 | $234K | Sell |
1,144
-150
| -12% | -$29.5K | ﹤0.01% | 294 |
|
|
2020
Q4 | $236K | Hold |
1,294
| – | – | ﹤0.01% | 272 |
|
|
2020
Q3 | $216K | Hold |
1,294
| – | – | ﹤0.01% | 272 |
|
|
2020
Q2 | $210K | Hold |
1,294
| – | – | ﹤0.01% | 265 |
|
|
2020
Q1 | $224K | Sell |
1,294
-67
| -5% | -$13.3K | ﹤0.01% | 251 |
|
|
2019
Q4 | $273K | Buy |
1,361
+42
| +3% | +$8.62K | ﹤0.01% | 264 |
|
|
2019
Q3 | $279K | Sell |
1,319
-189
| -13% | -$39.5K | ﹤0.01% | 259 |
|
|
2019
Q2 | $293K | Buy |
1,508
+189
| +14% | +$34.8K | 0.01% | 251 |
|
|
2019
Q1 | $217K | Buy |
+1,319
| New | +$233K | ﹤0.01% | 279 |
|
|
2014
Q1 | – | Sell |
-28,080
| Closed | -$2.2M | – | 220 |
|
|
2013
Q4 | $2.2M | Buy |
28,080
+80
| +0.3% | +$6.26K | 0.06% | 97 |
|
|
2013
Q3 | $2.07M | Hold |
28,000
| – | – | 0.08% | 75 |
|
|
2013
Q2 | $2.13M | Buy |
+28,000
| New | +$1.84M | 0.07% | 89 |
|
Other funds holding CME
Haverford Trust Company's CME Position: Q2 2026 in Review
Haverford Trust Company reduced its CME Group (CME) stake by 4.1% in Q2 2026, selling an estimated $734K and leaving 62,575 shares worth $13.8M. The position accounts for 0.12% of the portfolio, ranked #97.
Haverford Trust Company first reported a position in CME in Q2 2013 and has held it in 30 quarters since. The position peaked at $19.3M in Q1 2026. 1,694 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- Haverford Trust Company held 62,575 shares of CME Group worth $13.8M as of Q2 2026.
- Haverford Trust Company sold 2,655 CME Group shares in Q2 2026, an estimated $734K.
- CME Group made up 0.12% of Haverford Trust Company's portfolio in Q2 2026, its #97 holding.
- Haverford Trust Company first reported a position in CME Group in Q2 2013 and has held it in 30 quarters since.
- Haverford Trust Company's CME Group position peaked at $19.3M in Q1 2026.
- 1,694 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on Haverford Trust Company's 13F filing for Q2 2026, filed 12 Aug 2026.